Compounded semaglutide has emerged as a significant development in the management of obesity and type 2 diabetes. As a ...

U.S. representative from Austin asks Health and Human Services secretary to push for generic licensing of semaglutide ...

MangoRx aims to capitalize on growing demand for GLP-1 treatments to drive revenue growth and expand market share in the ...

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...

Noom is best known for its eponymous app that helps people become healthier and lose weight by making changes to their diet ...

Online companies like Noom and Hims & Hers this year began selling compounded semaglutide, the active ingredient in Ozempic ...

Compounding pharmacies have increasingly been at the centre of safety concerns around the legitimacy and credibility of ...

Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established ...

U.S. telehealth company Hims & Hers Health on Wednesday said it will sell compounded versions of Novo Nordisk's popular ...

An emerging market for compounded weight loss injections that mimic brand-name drugs such as Ozempic, Wegovy, Mounjaro and ...